ADA Obesity Association Releases 2026 Adult Obesity Diagnosis and Staging Standards
The ADA's new Obesity Association standards formalize race- and ethnicity-specific BMI thresholds plus waist-based confirmatory measures, reframing obesity diagnosis around adiposity rather than BMI alone.
Standards of Care in Overweight and Obesity 2026American Diabetes Association Obesity AssociationobesityoverweightBMIwaist circumferenceobesity pharmacotherapyweight-promoting medicationsEndocrinology / Obesity
Background Information
New obesity guidelines emphasize early screening and tailored diagnosis.
Obesity significantly increases the risk of chronic diseases and mortality, making early and accurate diagnosis essential for effective management. The guidelines recommend annual screening for excess adiposity using body mass index (BMI) with race- and ethnicity-specific thresholds for accurate diagnosis. Using these guidelines can improve early intervention strategies, risk assessment, and personalized management plans for adults with obesity. Annual screening and race-specific BMI criteria are key to effective obesity management.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Authors:American Diabetes Association Professional Practice Committee for Obesity
Citation:American Diabetes Association Professional Practice Committee for Obesity Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults: Standards of Care in Overweight and Obesity-2026. BMJ open diabetes research & care. 2026;13(Suppl 1). doi:10.1136/bmjdrc-2026-006247
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?
Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.